Drug Shortage Report for APO-TELMISARTAN-AMLODIPINE

Last updated on 2022-09-14 History
Report ID 156794
Drug Identification Number 02473496
Brand name AA-TELMISARTAN-AMLODIPINE
Common or Proper name AA TELM/AMLO
Company Name APOTEX INC
Market Status DORMANT
Active Ingredient(s) AMLODIPINE TELMISARTAN
Strength(s) 10MG 80MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100BTL
ATC code C09DB
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-04-06
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-09-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-03-16 English Compare
v2 2022-03-16 French Compare
v3 2022-04-01 English Compare
v4 2022-04-01 French Compare
v5 2022-04-07 English Compare
v6 2022-06-10 English Compare
v7 2022-06-10 French Compare
v8 2022-09-14 English Compare
v9 2022-09-14 French Compare

Showing 1 to 9 of 9